- Home
- ORGO vs LFMD Comparison
ORGO vs LFMD Comparison
Compare ORGO & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- LFMD
- Stock Information
- Founded
- ORGO 1985
- LFMD 1994
- Country
- ORGO United States
- LFMD United States
- Employees
- ORGO N/A
- LFMD N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- LFMD Medical/Nursing Services
- Sector
- ORGO Health Care
- LFMD Health Care
- Exchange
- ORGO Nasdaq
- LFMD Nasdaq
- Market Cap
- ORGO 465.6M
- LFMD 535.4M
- IPO Year
- ORGO N/A
- LFMD N/A
- Fundamental
- Price
- ORGO $4.89
- LFMD $6.33
- Analyst Decision
- ORGO Buy
- LFMD Buy
- Analyst Count
- ORGO 2
- LFMD 6
- Target Price
- ORGO $7.50
- LFMD $12.50
- AVG Volume (30 Days)
- ORGO 642.5K
- LFMD 2.8M
- Earning Date
- ORGO 08-07-2025
- LFMD 08-05-2025
- Dividend Yield
- ORGO N/A
- LFMD N/A
- EPS Growth
- ORGO N/A
- LFMD N/A
- EPS
- ORGO N/A
- LFMD N/A
- Revenue
- ORGO $429,531,000.00
- LFMD $245,563,670.00
- Revenue This Year
- ORGO $2.57
- LFMD $29.80
- Revenue Next Year
- ORGO $9.80
- LFMD $18.43
- P/E Ratio
- ORGO N/A
- LFMD N/A
- Revenue Growth
- ORGO N/A
- LFMD 37.74
- 52 Week Low
- ORGO $2.46
- LFMD $3.99
- 52 Week High
- ORGO $6.71
- LFMD $15.84
- Technical
- Relative Strength Index (RSI)
- ORGO 59.08
- LFMD 32.01
- Support Level
- ORGO $4.41
- LFMD $5.95
- Resistance Level
- ORGO $4.90
- LFMD $6.69
- Average True Range (ATR)
- ORGO 0.30
- LFMD 0.54
- MACD
- ORGO -0.03
- LFMD -0.05
- Stochastic Oscillator
- ORGO 92.58
- LFMD 5.61
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About LFMD LifeMD Inc.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.